24 October 2024
SpeeDx Appoints Jeremy Stackawitz as Chief Executive Officer to Drive Global Expansion of its Molecular Diagnostics Solutions
Sydney, Australia – October 24th, 2024 – SpeeDx, a leading innovator in molecular diagnostic solutions, today announced the appointment of Jeremy Stackawitz as Chief Executive Officer. With more than 25 years of leadership experience in the life sciences and diagnostics sectors, Stackawitz will focus on accelerating SpeeDx’s commercialization, partnering and regulatory activities across key markets, including the United States.